FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
BERLING HENRY A
(Last) (First) (Middle)
3803 EXETER ROAD
(Street)
RICHMOND VA 23221
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MEDICAL ACTION INDUSTRIES INC [ MDCI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.001 par value 10/01/2014   D   7,500 D $ 13.8 (1) $ 0 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Employee Director Stock Option Plan $ 12.45 (2) 10/01/2014   D     3,750   (3) 08/04/2015 Common Stock 3,750 $ 1.35 0 D  
Non-Employee Director Stock Option Plan $ 14.76 (4) 10/01/2014   D     3,750   (5) 08/17/2016 Common Stock 3,750 $ 0 0 D  
Non-Employee Director Stock Option Plan $ 22.10 10/01/2014   D     2,500   (5) 08/16/2017 Common Stock 2,500 $ 0 0 D  
Non-Employee Director Stock Option Plan $ 13.25 10/01/2014   D     2,500   (6) 08/14/2018 Common Stock 2,500 $ 0.55 0 D  
Non-Employee Director Stock Option Plan $ 12.59 10/01/2014   D     7,500   (7) 08/13/2019 Common Stock 7,500 $ 1.21 0 D  
Non-Employee Director Stock Option Plan $ 8.99 10/01/2014   D     7,500   (8) 08/12/2020 Common Stock 7,500 $ 4.81 0 D  
Non-Employee Director Stock Option Plan $ 3.57 10/01/2014   D     15,000   (9) 08/09/2022 Common Stock 15,000 $ 10.23 0 D  
Non-Employee Director Stock Option Plan $ 6.35 10/01/2014   D     7,500   (10) 08/08/2023 Common Stock 7,500 $ 7.45 0 D  
Explanation of Responses:
1. Disposed of pursuant to the merger agreement (the "Merger Agreement") between Issuer, Owens & Minor, Inc. and Mongoose Merger Sub Inc. in exchange for the merger consideration of $13.80 per share (the "Merger Consideration").
2. The reporting person's 2,500 stock options, at the exercise price of $18.68 were granted on 08/04/05. As a result of a stock split, which was paid on 02/09/07, the number of options has been adjusted to 3,750 and the exercise price has decreased to $12.45, as rounded to the nearest hundredth.
3. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $5,050, as rounded, representing the difference between the exercise price of the option and the Merger Consideration.
4. The reporting person's 2,500 stock options, at the exercise price of $22.14, were granted on 08/17/06. As a result of a stock split, which was paid on 02/09/07, the number of options has been adjusted to 3,750 and the exercise price has decreased to $14.76.
5. This option was cancelled without any consideration because the exercise price of the option exceeded the Merger Consideration.
6. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1,375, representing the difference between the exercise price of the option and the Merger Consideration.
7. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $9,075, representing the difference between the exercise price of the option and the Merger Consideration.
8. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $36,075, representing the difference between the exercise price of the option and the Merger Consideration.
9. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $153,450, representing the difference between the exercise price of the option and the Merger Consideration.
10. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $55,875, representing the difference between the exercise price of the option and the Merger Consideration.
/s/ Henry A Berling 10/02/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.